Trial intelligence / Profile preview

PTS Intratumoral Injection for Central Airway NSCLC Obstruction

NCT03448146Phase 3Completed

Sponsor
PTS International
Start
Aug 2009
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of para-toluenesulfonamide in non-small cell lung cancer (NSCLC), sponsored by PTS International. Started Aug 2009; status: completed.

02

Drugs

para-toluenesulfonamide
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT03448146.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03448146.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call